Latest1 information on COVID-19

Rapid Turnaround, Home-based Saliva Testing for COVID-19

Recruiting

I'm Interested

Trial ID: NCT04568122

Age - 2 Years-N/A Gender - All Accepting Healthy Volunteers - yes

Purpose

The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection. Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.

Official Title

Rapid Turnaround, Home-based Saliva Testing for COVID-19

Stanford Investigator(s)

Manu Prakash

Euan A. Ashley
Euan A. Ashley

Associate Dean, School of Medicine, Roger and Joelle Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology

Eligibility


Inclusion Criteria:

   - Hospitalized patients

      - Hospitalized at Stanford Health Care for COVID-related complications and tested
      positive for SARS-CoV-2 with a PCR-based test

      - Able to understand and consent to study and with a clinical trajectory likely to
      be consistent with multi-day participation

   - High-risk/positive population

      - Seeking testing for suspected COVID or a participant in a study of COVID-positive
      outpatients

      - Own an internet-enabled phone or device capable of loading web pages, receiving
      text messages, and taking/uploading photos.

      - Willing to participate in the study for 6 months

   - Low-risk population

      - Own an internet-enabled phone or device capable of loading web pages, receiving
      text messages, and taking/uploading photos.

      - Willing to participate in the study for 6 months

Exclusion Criteria:

   - All participants:

      - Participants with salivary gland dysfunction (including patients with Sjogren's
      disease or those with xerostomia associated with lupus or rheumatoid arthritis)

      - Participants will not be eligible if they identify any reason they are unable to
      participate in the study

   - High-risk/positive population

      - Participants who have color blindness

      - Participants unable to operate the SnapDx device

   - Low-risk population

      - Participants with prior confirmed SARS-CoV-2 infection

      - Participants who have color blindness

      - Participants unable to operate the SnapDx device

View More
View Less

Intervention(s):

device: Saliva test kit

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Study Team
650-374-0085

©2022 Stanford Medicine